Lupin launches generic version of Oracea capsules in US

The company said it has launched the medication, indicated for the treatment of inflammatory lesions (papules and pustules) of rosacea, following approval from the US Food and Drug Administration (USFDA).

Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *